相关实验视频

Updated: Jan 22, 2026

Assessment of Vascular Function in Patients With Chronic Kidney Disease

Assessment of Vascular Function in Patients With Chronic Kidney Disease

Published on: June 16, 2014

在患有慢性粒状瘤疾病的患者中,I型干扰素特征升高

Ridhima Aggarwal¹, Pandiarajan Vignesh², Aditya Dod³

¹DM Pediatric Clinical Immunology and Rheumatology, MD Pediatrics, Post Doctoral Fellow, Allergy and Immunology Unit, Department of Pediatrics, Advanced Pediatrics Center, Postgraduate Institute of Medical Education and Research, Chandigarh - 160012, India.

Clinical and experimental immunology

|January 21, 2026

概括

患有高炎症的慢性颗粒性疾病 (CGD) 患者表现出高的1型干扰素特征. 单细胞CD169表达是CGD中这种干扰素特征的可靠标记.

科学领域:

免疫学免疫学免疫学
遗传学遗传学是一个

背景情况:

慢性颗粒性疾病 (CGD) 的特点是经常性感染和炎症.
导致CGD高炎症的确切机制尚不清楚.

研究的目的:

为了研究CGD患者的1型干扰素特征.
量化Siglec-1/CD169在单细胞上的表达,与CGD严重程度相关.

主要方法:

从CGD患者和对照患者的外周血液单核细胞 (PBMC) 的转录组分析.
流细胞计测量用于测量单细胞CD169的表达.
用RT-PCR来评估1型干扰素刺激基因 (ISG).

主要成果:

患有CGD的患者表现出1型干扰素刺激基因 (ISG) 的升高.
与无症状或传染病亚组相比,具有炎症表现的CGD患者的单细胞CD169表达显着更高.
CD169表达与1型干扰素得分正相关.

结论:

在CGD中,超炎症与明显的1型干扰素特征有关.
单细胞上的CD169是评估CGD中的1型干扰素特征的潜在生物标志物.

关键词:

这是CYBB的运营商.CD169 是一个CD169 是一个CD169 有关RNA测序的研究.这是RT-PCR.西格莱克-1 标志一类干扰子的签名签名.这是自发炎症.慢性颗粒状细胞性疾病流动细胞计是流动细胞计.单细胞 (Monocytes) 是一种单细胞.

更多相关视频

High-throughput Quantitative Real-time RT-PCR Assay for Determining Expression Profiles of Types I and III Interferon Subtypes

High-throughput Quantitative Real-time RT-PCR Assay for Determining Expression Profiles of Types I and III Interferon Subtypes

Published on: March 24, 2015

Author Spotlight: Exploring Non-Pharmacological Therapies for Chronic Respiratory Diseases — Linking Intestinal Microbiome Insights to COPD Treatment

Author Spotlight: Exploring Non-Pharmacological Therapies for Chronic Respiratory Diseases — Linking Intestinal Microbiome Insights to COPD Treatment

Published on: December 27, 2024

相关概念视频

Chronic Obstructive Pulmonary Disease

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...

Freezing Point Depression and Boiling Point Elevation

Freezing Point Depression and Boiling Point Elevation

Boiling Point Elevation
The boiling point of a liquid is the temperature at which its vapor pressure is equal to ambient atmospheric pressure. Since the vapor pressure of a solution is lowered due to the presence of nonvolatile solutes, it stands to reason that the solution’s boiling point will subsequently be increased. Vapor pressure increases with temperature, and so a solution will require a higher temperature than will pure solvent to achieve any given vapor pressure, including one...

Chronic Obstructive Pulmonary Disease-I: Introduction

Chronic Obstructive Pulmonary Disease-I: Introduction

Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.

Chronic Obstructive Pulmonary Disease-V: Management

Chronic Obstructive Pulmonary Disease-V: Management

Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...